22 Scopus citations


The numbers of insulin-secreting pancreatic beta cells are reduced in people with type 1 and type 2 diabetes. Driving beta cell regeneration in the pancreases of people with diabetes would be an attractive approach to reversing diabetes. While adult human beta cells have long been believed to be terminally differentiated and, therefore, irreversibly quiescent, it has become clear over recent years that this is not true. More specifically, both candidate and unbiased high-throughput screen approaches have revealed several classes of molecules that are clearly able to induce human beta cell proliferation. Here, we review recent approaches and accomplishments in human beta cell regenerative drug discovery. We also list the challenges that this rapidly moving field must confront to translate beta cell regenerative therapy from the laboratory to the clinic.

Original languageEnglish
Pages (from-to)1693-1699
Number of pages7
Issue number8
StatePublished - 1 Aug 2018


  • Beta cell
  • Diabetes
  • Drug discovery
  • High-throughput screen
  • Human
  • Pancreas
  • Proliferation
  • Regeneration
  • Review


Dive into the research topics of 'Advances in drug discovery for human beta cell regeneration'. Together they form a unique fingerprint.

Cite this